a developer of drugs for the treatment of anemia and vascular diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, AKBA has been loosely correlated with INZY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AKBA jumps, then INZY could also see price increases.
Ticker / NAME | Correlation To AKBA | 1D Price Change % | ||
---|---|---|---|---|
AKBA | 100% | -3.05% | ||
INZY - AKBA | 42% Loosely correlated | -4.11% | ||
ABCL - AKBA | 41% Loosely correlated | -2.11% | ||
BEAM - AKBA | 41% Loosely correlated | -4.05% | ||
NTLA - AKBA | 40% Loosely correlated | -5.41% | ||
PRME - AKBA | 37% Loosely correlated | -10.54% | ||
More |
Ticker / NAME | Correlation To AKBA | 1D Price Change % |
---|---|---|
AKBA | 100% | -3.05% |
Pharmaceuticals category (312 stocks) | 24% Poorly correlated | -0.19% |